Skip to content

Vicor Models 410B, 410D, and Modified 410A Pacemaker

by Telectronics and Cordis Pacing Systems

510(k) K881711

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK881711 Date26 May 1988ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Vicor Models 410B & 410D and Modified 410A Pacema.
510(k) Number
FDA Product Code
DXY
Models / Variants
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Vicor Models 410B, 410D, and Modified 410A are implantable pacemaker pulse generators, classified under FDA code DXY. These devices provide a power supply and electronic circuitry to generate periodic electrical pulses, serving as a substitute for the heart’s intrinsic pacing system to manage cardiac rhythm disorders, including both intermittent and continuous abnormalities.

These pacemakers are intended for implantation and are regulated under FDA 510(k) clearance K881711, falling under device class III (870.3610). They are designed for single-use implantation and are not reusable. No specific MRI safety or sterility details are provided in the data, but they are governed by cardiovascular regulatory standards. The models are identified by their unique reference codes (410B, 410D, and Modified 410A) and are registered under multiple FDA registration numbers.

Other devices from Telectronics and Cordis Pacing Systems

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these pacemakers designed for reuse or are they single-use devices intended for one-time implantation?

    The Vicor Models 410B, 410D, and Modified 410A are explicitly designed for single-use implantation only. The device description confirms they are not intended for reuse, aligning with standard practices for implantable pulse generators to ensure patient safety and sterility.

  • What specific cardiac rhythm disorders are these pacemakers intended to manage, and how do they function?

    These pacemakers are intended to manage cardiac rhythm disorders, including both intermittent and continuous abnormalities, by serving as a substitute for the heart’s intrinsic pacing system. They generate periodic electrical pulses to regulate heartbeats when the natural conduction system fails, ensuring proper cardiac rhythm.

  • How are these devices supplied, and what should clinicians consider regarding their handling before implantation?

    The Vicor Models 410B, 410D, and Modified 410A are implantable pulse generators supplied as sterile devices for surgical implantation. While the data does not specify explicit sterility assurances (e.g., terminal sterilization method), they are governed by cardiovascular regulatory standards, implying adherence to industry best practices for sterility and handling. Clinicians should follow standard aseptic techniques during implantation.

  • What distinguishes the Vicor Models 410B, 410D, and Modified 410A from each other, and how are they identified?

    The models are differentiated by their unique reference codes: 410B, 410D, and Modified 410A. These distinctions likely reflect variations in specifications (e.g., pacing modes, battery life, or programming features), though the provided data does not detail these differences. They are all registered under multiple FDA registration numbers, confirming their individual regulatory tracking.

  • What regulatory pathway was followed for FDA clearance of these devices, and what does this imply for their safety and efficacy?

    These pacemakers were cleared via the FDA 510(k) pathway (K881711), classified under device class III (870.3610) and reviewed by the Cardiovascular (CV) Advisory Committee. The decision was marked as *Substantially Equivalent (SESE)*, meaning they were deemed comparable to legally marketed devices in terms of safety and effectiveness. This pathway ensures rigorous evaluation of implantable cardiac devices.